These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28138443)

  • 21. [Short-term efficacy comparison between preoperative three dimensional conformal radiotherapy and volumetric modulated arc therapy concurrently combined with chemotherapy in the treatment of locally advanced rectal carcinoma].
    Xiao L; Yu X; Zhu Y; Xiao W; Zeng Z; Liu M; Zhang R; Gao Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jul; 19(7):769-75. PubMed ID: 27452754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indications for Lateral Pelvic Lymph Node Dissection Based on Magnetic Resonance Imaging Before and After Preoperative Chemoradiotherapy in Patients with Advanced Low-Rectal Cancer.
    Akiyoshi T; Matsueda K; Hiratsuka M; Unno T; Nagata J; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S614-20. PubMed ID: 25896145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative Chemoradiotherapy Might Improve the Prognosis of Patients with Locally Advanced Low Rectal Cancer and Lateral Pelvic Lymph Node Metastases.
    Nagasaki T; Akiyoshi T; Fujimoto Y; Konishi T; Nagayama S; Fukunaga Y; Ueno M
    World J Surg; 2017 Mar; 41(3):876-883. PubMed ID: 27730348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of pathologic staging with magnetic resonance imaging after preoperative chemoradiotherapy in rectal cancer: pooled analysis of KROG 10-01 and 11-02.
    Lee JH; Jang HS; Kim JG; Lee MA; Kim DY; Kim TH; Oh JH; Park SC; Kim SY; Baek JY; Park HC; Kim HC; Nam TK; Chie EK; Jung JH; Oh ST
    Radiother Oncol; 2014 Oct; 113(1):18-23. PubMed ID: 25245559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case report of pathologically complete response of rectal cancer after preoperative treatment of CPT-11, S-1, and radiation therapy].
    Hamanaka M; Yamano T; Noda M; Tsukamoto K; Kuno T; Yamagishi D; Babaya A; Matsubara N; Kamikonya N; Tomita N
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2253-5. PubMed ID: 22202346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncologic impact of pathologic response on clinical outcome after preoperative chemoradiotherapy in locally advanced rectal cancer.
    Yoon WH; Kim HJ; Kim CH; Joo JK; Kim YJ; Kim HR
    Ann Surg Treat Res; 2015 Jan; 88(1):15-20. PubMed ID: 25553320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and short-term outcomes of preoperative chemoradiotherapy with intermittent oral tegafur-uracil plus leucovorin in Japanese rectal cancer patients: a single center experience retrospective analysis.
    Nakagawa R; Inoue Y; Ohki T; Kaneko Y; Maeda F; Yamamoto M
    World J Surg Oncol; 2017 May; 15(1):112. PubMed ID: 28566093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility of Selective Lateral Node Dissection Based on Magnetic Resonance Imaging in Rectal Cancer After Preoperative Chemoradiotherapy.
    Park BK; Lee SJ; Hur BY; Kim MJ; Chan Park S; Chang HJ; Kim DY; Oh JH
    J Surg Res; 2018 Dec; 232():227-233. PubMed ID: 30463722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological analysis of distal margin for rectal cancer after preoperative chemoradiation therapy.
    Nishioka M; Shimada M; Kurita N; Iwata T; Morimoto S; Yoshikawa K; Higashijima J; Miyatani T
    Hepatogastroenterology; 2012 Oct; 59(119):2142-6. PubMed ID: 22366527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case of successful radical resection of rectal cancer with neo-adjuvant chemoradiotherapy].
    Ami K; Kawai Y; Seki R; Gokita K; Takeuchi S; Fujiya K; Takasaki J; Amagasa H; Kamikozuru H; Ganno H; Imai K; Fukuda A; Nagahama T; Ando M; Okada Y; Tei S; Arai K
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1987-9. PubMed ID: 24393988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diffusion-weighted imaging for evaluating lymph node eradication after neoadjuvant chemoradiation therapy in locally advanced rectal cancer.
    Ryu KH; Kim SH; Yoon JH; Lee Y; Paik JH; Lim YJ; Lee KH
    Acta Radiol; 2016 Feb; 57(2):133-41. PubMed ID: 25638800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlations between the Recurrence Patterns and Sizes of Lateral Pelvic Lymph Nodes before and after Chemoradiotherapy in Patients with Lower Rectal Cancer.
    Shiratori H; Kawai K; Hata K; Tanaka T; Nishikawa T; Sasaki K; Kaneko M; Murono K; Emoto S; Morikawa T; Fukayama M; Nozawa H
    Oncology; 2019; 96(1):33-43. PubMed ID: 30212816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative Outcomes of Preoperative Chemoradiotherapy and Selective Postoperative Chemoradiotherapy in Clinical Stage T3N0 Low and Mid Rectal Cancer.
    Lin Y; Lin H; Xu Z; Zhou S; Chi P
    J Invest Surg; 2019 Nov; 32(7):679-687. PubMed ID: 30215538
    [No Abstract]   [Full Text] [Related]  

  • 34. [Three-Year Survival after Lymphadenectomy for Residual Lymph Node Metastasis of Esophageal Cancer with Invasion into the Trachea and Carotid Artery after Chemoradiotherapy - A Case Report].
    Odagiri K; Yamazaki M; Tanaka K; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Nakajima K; Mori M; Doki Y
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):2006-2008. PubMed ID: 29394849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Total neoadjuvant approach with FOLFOXIRI plus bevacizumab followed by chemoradiotherapy plus bevacizumab in locally advanced rectal cancer: the TRUST trial.
    Masi G; Vivaldi C; Fornaro L; Lonardi S; Buccianti P; Sainato A; Marcucci L; Martignetti A; Luca Urso ED; Castagna M; Fontanini G; Bergamo F; Musettini G; Urbani L; Sensi E; Balestri R; Montrone S; Pasqualetti F; Cremolini C; Di Paolo A; Zagonel V; Falcone A
    Eur J Cancer; 2019 Mar; 110():32-41. PubMed ID: 30739838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Locally Advanced Rectal Cancer Presenting with Perforation That Was Successfully Resected after Preoperative Chemotherapy with mFOLFOX6 plus Panitumumab].
    Sakabe R; Sakoda T; Yoshimura K; Murao N; Kuwada A; Tahara K; Hotei H; Maeda Y
    Gan To Kagaku Ryoho; 2019 Mar; 46(3):475-477. PubMed ID: 30914588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reevaluation of Preoperative Chemoradiotherapy for Clinical T3 Lower Rectal Cancer: A Multicenter Collaborative Retrospective Clinical Study.
    Takeda M; Kawahara H; Ogawa M; Suwa K; Eto K; Yanaga K
    Anticancer Res; 2019 Jun; 39(6):3047-3052. PubMed ID: 31177147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Local recurrence after five years is associated with preoperative chemoradiotherapy treatment in patients diagnosed with stage II and III rectal cancer.
    Marin G; Suárez J; Vera R; Balén E; Viudez A; Mata E
    Int J Surg; 2017 Aug; 44():15-20. PubMed ID: 28583894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of lymph node size to predict nodal metastasis in patients with rectal cancer after preoperative chemoradiotherapy.
    Kim IK; Kang J; Lim BJ; Sohn SK; Lee KY
    Int J Colorectal Dis; 2015 Apr; 30(4):459-64. PubMed ID: 25586204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical implications of preoperative chemoradiotherapy prior to laparoscopic surgery for locally advanced low rectal cancer.
    Kondo K; Shimbo T; Tanaka K; Yamamoto M; Narumi Y; Okuda J; Uchiyama K
    Mol Clin Oncol; 2017 Jan; 6(1):23-28. PubMed ID: 28123724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.